Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Pulse vs Sequential Steroid Therapy for Graves' Orbitopathy
NCT01969019Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Jan 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in Graves' ophthalmopathy (TED), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NCT01969019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969019.